Received May 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
infection; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of infection in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced infection (Verbatim: infection). The outcome of the infection was not reported. The reporter considered the infection to be unrelated to Shingles vaccine. The company considered the infection to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 10-MAY-2026 This case was reported by a patient via interactive digital media. The shingles vaccine did not lessened the amount of infections. The batch number was not provided and unable to contact the reporter.